PhytoHealth Corporation (TPE:4108)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.60
+0.15 (1.12%)
Mar 5, 2026, 1:34 PM CST
Market Cap2.70B -16.6%
Revenue (ttm)134.58M -12.4%
Net Income-58.20M
EPS-0.29
Shares Out198.62M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume124,943
Average Volume292,794
Open13.50
Previous Close13.45
Day's Range13.50 - 13.75
52-Week Range11.00 - 17.90
Beta0.38
RSI41.90
Earnings DateFeb 24, 2026

About PhytoHealth

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment eng... [Read more]

Sector Healthcare
Founded 1998
Employees 84
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4108
Full Company Profile

Financial Performance

In 2025, PhytoHealth's revenue was 134.58 million, a decrease of -12.36% compared to the previous year's 153.56 million. Losses were -58.20 million, -20.82% less than in 2024.

Financial Statements